FibroBiologics

FibroBiologics FibroBiologics holds 270+ patents.

Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials.

09/10/2026

What if age-related changes to the immune system weren’t something we simply had to accept?

The thymus plays a critical role in T-cell development, yet its function naturally declines with age. FibroBiologics is exploring fibroblast-based thymus organoids in preclinical research to better understand whether thymic function and T-cell production could one day be supported in new ways.

It’s a different way of looking at longevity, not simply adding years, but exploring the biology behind healthier aging.

“Stop counting the years in your life. Start fighting for the life in your years.”

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

What if an important part of regenerative medicine has been in the body all along?Fibroblasts are naturally involved in ...
09/09/2026

What if an important part of regenerative medicine has been in the body all along?

Fibroblasts are naturally involved in processes including tissue repair, regeneration, and immune signaling.

At FibroBiologics, we’re studying how these cells and their unique biological properties could be harnessed in the development of new cell-based therapies.

The future of medicine may not always begin with something new. Sometimes it begins by understanding what the body already knows how to do.

NASDAQ: FBLG

👉 Learn more: bit.ly/how-immunity-ages

09/08/2026

A healthy immune system isn’t simply stronger. It’s balanced.

It needs to recognize genuine threats while knowing when to leave healthy tissue alone. That balance is known as immune homeostasis, and it plays an important role in how the immune system functions.

FibroBiologics is researching fibroblast-based approaches and thymus science to better understand how immune balance may be supported.

The future of immune health may not be about simply turning the immune system up or down. It may be about helping it find the right balance.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

As we age, the immune system changes too.One important part of that story is the thymus, the organ responsible for helpi...
09/07/2026

As we age, the immune system changes too.

One important part of that story is the thymus, the organ responsible for helping develop T cells that play a key role in immune defense.

Over time, thymic function declines, which can contribute to changes in how effectively the immune system responds.

That is why FibroBiologics is studying new approaches aimed at understanding and potentially supporting immune function as we age.

The goal is bigger than managing age-related disease. It is understanding what changes biologically, and whether science can address it differently.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

FibroBiologics (Nasdaq: FBLG) announced that the USPTO has issued a Patent titled: Therapeutic Use of Fibroblasts for Us...
09/03/2026

FibroBiologics (Nasdaq: FBLG) announced that the USPTO has issued a Patent titled: Therapeutic Use of Fibroblasts for Use in Wound Healing. The patent covers methods of treating and accelerating the healing of wounds by topically administering a composition comprising 3D spheroid fibroblasts or fibroblast-derived materials.

The covered wound types span diabetic foot ulcers, venous leg ulcers, pressure wounds, bedsores, burns, cuts, and abrasions. In preclinical studies described in the patent, treated wounds healed significantly faster than controls in both diabetic and non-diabetic models. These findings are preclinical, and safety and efficacy have not been established.

For more information, please visit: https://bit.ly/4gMuEsZ

09/03/2026

There’s a small organ behind your breastbone with a very important job: helping train your immune system.

The thymus plays a central role in the development of T cells, which help the body identify and respond to threats. But as we age, the thymus gradually shrinks and much of its functional tissue is replaced by fat.

That age-related process is one reason researchers are studying the connection between the thymus, immune function, and healthy longevity.

At FibroBiologics, thymus science is one area being explored as part of our broader fibroblast research.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

Fibroblasts are everywhere in the human body, yet they have received far less attention than stem cells in regenerative ...
09/02/2026

Fibroblasts are everywhere in the human body, yet they have received far less attention than stem cells in regenerative medicine.

FibroBiologics is working to change that.

Our research is focused on understanding the regenerative and immune-modulating potential of fibroblasts and how these cells could open new possibilities for the treatment of chronic disease.
Sometimes the biggest opportunities in science come from looking more closely at what has been overlooked.

NASDAQ: FBLG

👉 Learn more: bit.ly/how-immunity-ages

09/01/2026

A stronger immune system isn’t always a smarter immune system.

For decades, many treatments have approached immune dysfunction by turning the response either down or up. But both extremes can create challenges.

The bigger question is: what if the goal isn’t simply more or less immunity, but better immune balance?

That’s part of what FibroBiologics is exploring through fibroblast research, studying how these cells interact with and may help modulate the immune system.

You don’t want more immunity. You want smarter immunity.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

What if we could help the immune system rebuild one of its most important functions?FibroBiologics is exploring a thymus...
09/01/2026

What if we could help the immune system rebuild one of its most important functions?

FibroBiologics is exploring a thymus organoid approach designed to study whether selected cells can help support the production of T cells, a critical part of immune function.

This research is still preclinical, but it represents an exciting area of study at the intersection of immunology, aging, and longevity.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

08/27/2026

What does it take to build a thymus organoid?

At FibroBiologics, researchers combine fibroblasts, thymic epithelial cells, and T-cell progenitors to create a three-dimensional thymus organoid.

In preclinical research, these organoids:
Self-assemble without artificial scaffolds
Are ready in approximately three days
Can be frozen, thawed, and remain functional
Are designed for injection rather than surgery

In laboratory studies, the organoids activated the same biological signals used by a natural thymus and supported the development of functional T cells.

This work is part of our ongoing research into immune longevity and regenerative medicine.

NASDAQ: FBLG
Follow along as we continue exploring the future of fibroblast science.

Address

Houston, TX

Website

Alerts

Be the first to know and let us send you an email when FibroBiologics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to FibroBiologics:

Shortcuts

Share

Category